ALBO Annual Net Income
-$34.03 M
+$73.60 M+68.38%
31 December 2021
Summary:
As of February 5, 2025, ALBO annual net profit is -$34.03 million, with the most recent change of +$73.60 million (+68.38%) on December 31, 2021. During the last 3 years, it has risen by +$12.08 million (+26.20%).ALBO Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALBO Quarterly Net Income
-$37.80 M
+$2.15 M+5.38%
30 September 2022
Summary:
As of February 5, 2025, ALBO quarterly net profit is -$37.80 million, with the most recent change of +$2.15 million (+5.38%) on September 30, 2022. Over the past year, it has dropped by -$94.89 million (-166.22%).ALBO Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALBO TTM Net Income
-$131.15 M
-$94.89 M-261.69%
30 September 2022
Summary:
As of February 5, 2025, ALBO TTM net profit is -$131.15 million, with the most recent change of -$94.89 million (-261.69%) on September 30, 2022. Over the past year, it has dropped by -$83.28 million (-173.98%).ALBO TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALBO Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +68.4% | -166.2% | -174.0% |
| 3 y3 years | +26.2% | -72.5% | -109.1% |
| 5 y5 years | -39.4% | -480.6% | -109.1% |
ALBO Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +4296.6% | -166.2% | >+9999.0% |
Albireo Pharma Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$37.80 M(-5.4%) | -$131.15 M(+261.7%) |
| June 2022 | - | -$39.95 M(-5.9%) | -$36.26 M(+10.8%) |
| Mar 2022 | - | -$42.43 M(+287.1%) | -$32.73 M(-3.8%) |
| Dec 2021 | -$34.03 M(-68.4%) | -$10.96 M(-119.2%) | -$34.03 M(-28.9%) |
| Sept 2021 | - | $57.09 M(-256.7%) | -$47.87 M(-64.7%) |
| June 2021 | - | -$36.42 M(-16.7%) | -$135.70 M(+13.2%) |
| Mar 2021 | - | -$43.73 M(+76.3%) | -$119.88 M(+11.4%) |
| Dec 2020 | -$107.63 M(+71.6%) | -$24.80 M(-19.3%) | -$107.63 M(+19.1%) |
| Sept 2020 | - | -$30.74 M(+49.2%) | -$90.36 M(+10.8%) |
| June 2020 | - | -$20.60 M(-34.6%) | -$81.52 M(+5.1%) |
| Mar 2020 | - | -$31.49 M(+318.6%) | -$77.55 M(+23.6%) |
| Dec 2019 | -$62.72 M(+36.0%) | -$7.52 M(-65.7%) | -$62.72 M(-11.7%) |
| Sept 2019 | - | -$21.91 M(+31.8%) | -$71.06 M(+12.5%) |
| June 2019 | - | -$16.63 M(-0.2%) | -$63.17 M(+3.3%) |
| Mar 2019 | - | -$16.66 M(+5.0%) | -$61.15 M(+32.6%) |
| Dec 2018 | -$46.11 M(+88.9%) | -$15.86 M(+13.1%) | -$46.11 M(+30.6%) |
| Sept 2018 | - | -$14.03 M(-4.0%) | -$35.30 M(+27.0%) |
| June 2018 | - | -$14.60 M(+802.0%) | -$27.79 M(+43.5%) |
| Mar 2018 | - | -$1.62 M(-68.0%) | -$19.36 M(-20.7%) |
| Dec 2017 | -$24.41 M(+49.3%) | -$5.06 M(-22.3%) | -$24.41 M(+26.1%) |
| Sept 2017 | - | -$6.51 M(+5.4%) | -$19.36 M(+34.2%) |
| June 2017 | - | -$6.18 M(-7.4%) | -$14.42 M(+27.2%) |
| Mar 2017 | - | -$6.67 M(+323.0%) | -$11.34 M(-17.5%) |
| Dec 2016 | -$16.35 M(+18.9%) | - | - |
| Sept 2016 | - | -$1.58 M(-49.0%) | -$13.76 M(-10.7%) |
| Sept 2016 | -$13.76 M(-26.6%) | - | - |
| June 2016 | - | -$3.10 M(-47.3%) | -$15.41 M(-17.9%) |
| Mar 2016 | - | -$5.87 M(+82.5%) | -$18.78 M(+8.8%) |
| Dec 2015 | - | -$3.21 M(-0.5%) | -$17.27 M(-7.9%) |
| Sept 2015 | -$18.74 M(+32.6%) | -$3.23 M(-50.0%) | -$18.74 M(+5.3%) |
| June 2015 | - | -$6.46 M(+48.3%) | -$17.79 M(+22.4%) |
| Mar 2015 | - | -$4.36 M(-7.1%) | -$14.53 M(-11.2%) |
| Dec 2014 | - | -$4.69 M(+105.0%) | -$16.38 M(+15.9%) |
| Sept 2014 | -$14.13 M(-26.9%) | -$2.29 M(-28.7%) | -$14.13 M(+11.6%) |
| June 2014 | - | -$3.20 M(-48.3%) | -$12.66 M(-33.7%) |
| Mar 2014 | - | -$6.20 M(+153.7%) | -$19.09 M(+5.4%) |
| Dec 2013 | - | -$2.44 M(+199.8%) | -$18.11 M(-6.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2013 | -$19.34 M(-6.8%) | -$815.00 K(-91.5%) | -$19.34 M(-20.8%) |
| June 2013 | - | -$9.63 M(+84.5%) | -$24.40 M(+17.2%) |
| Mar 2013 | - | -$5.22 M(+42.3%) | -$20.82 M(+4.5%) |
| Dec 2012 | - | -$3.67 M(-37.6%) | -$19.91 M(-4.0%) |
| Sept 2012 | -$20.75 M(+95.9%) | -$5.88 M(-2.8%) | -$20.75 M(+93.3%) |
| June 2012 | - | -$6.05 M(+40.2%) | -$10.73 M(+24.0%) |
| Mar 2012 | - | -$4.32 M(-4.1%) | -$8.66 M(-11.5%) |
| Dec 2011 | - | -$4.50 M(-208.9%) | -$9.78 M(-7.6%) |
| Sept 2011 | -$10.59 M(-72.3%) | $4.13 M(-204.0%) | -$10.59 M(-53.6%) |
| June 2011 | - | -$3.97 M(-27.0%) | -$22.83 M(-16.9%) |
| Mar 2011 | - | -$5.44 M(+2.5%) | -$27.48 M(-15.3%) |
| Dec 2010 | - | -$5.31 M(-34.5%) | -$32.45 M(-15.3%) |
| Sept 2010 | -$38.29 M(-11.5%) | -$8.10 M(-6.1%) | -$38.29 M(-5.8%) |
| June 2010 | - | -$8.63 M(-17.1%) | -$40.66 M(-5.8%) |
| Mar 2010 | - | -$10.41 M(-6.6%) | -$43.17 M(-2.7%) |
| Dec 2009 | - | -$11.15 M(+6.5%) | -$44.39 M(+2.6%) |
| Sept 2009 | -$43.27 M(-0.2%) | -$10.47 M(-6.1%) | -$43.27 M(-4.8%) |
| June 2009 | - | -$11.15 M(-4.1%) | -$45.47 M(+2.3%) |
| Mar 2009 | - | -$11.63 M(+16.0%) | -$44.43 M(+4.9%) |
| Dec 2008 | - | -$10.02 M(-20.9%) | -$42.36 M(-2.3%) |
| Sept 2008 | -$43.36 M(+92.3%) | -$12.66 M(+25.3%) | -$43.36 M(+6.5%) |
| June 2008 | - | -$10.11 M(+5.8%) | -$40.69 M(+18.8%) |
| Mar 2008 | - | -$9.56 M(-13.3%) | -$34.25 M(+14.5%) |
| Dec 2007 | - | -$11.03 M(+10.3%) | -$29.91 M(+32.6%) |
| Sept 2007 | -$22.55 M(+179.5%) | -$10.00 M(+172.6%) | -$22.55 M(+51.8%) |
| June 2007 | - | -$3.67 M(-29.7%) | -$14.86 M(+10.1%) |
| Mar 2007 | - | -$5.21 M(+42.2%) | -$13.49 M(+27.5%) |
| Dec 2006 | - | -$3.67 M(+59.1%) | -$10.59 M(+31.2%) |
| Sept 2006 | -$8.07 M(+138.5%) | -$2.31 M(0.0%) | -$8.07 M(+22.1%) |
| June 2006 | - | -$2.31 M(0.0%) | -$6.61 M(+28.4%) |
| Mar 2006 | - | -$2.31 M(+100.3%) | -$5.15 M(+39.6%) |
| Dec 2005 | - | -$1.15 M(+36.1%) | -$3.69 M(+9.0%) |
| Sept 2005 | -$3.38 M(+337.1%) | -$846.00 K(0.0%) | -$3.38 M(+33.3%) |
| June 2005 | - | -$846.00 K(0.0%) | -$2.54 M(+50.0%) |
| Mar 2005 | - | -$846.00 K(0.0%) | -$1.69 M(+100.0%) |
| Dec 2004 | - | -$846.00 K | -$846.00 K |
| Sept 2004 | -$774.00 K | - | - |
FAQ
- What is Albireo Pharma annual net profit?
- What is the all time high annual net income for Albireo Pharma?
- What is Albireo Pharma annual net income year-on-year change?
- What is Albireo Pharma quarterly net profit?
- What is the all time high quarterly net income for Albireo Pharma?
- What is Albireo Pharma quarterly net income year-on-year change?
- What is Albireo Pharma TTM net profit?
- What is the all time high TTM net income for Albireo Pharma?
- What is Albireo Pharma TTM net income year-on-year change?
What is Albireo Pharma annual net profit?
The current annual net income of ALBO is -$34.03 M
What is the all time high annual net income for Albireo Pharma?
Albireo Pharma all-time high annual net profit is -$774.00 K
What is Albireo Pharma annual net income year-on-year change?
Over the past year, ALBO annual net profit has changed by +$73.60 M (+68.38%)
What is Albireo Pharma quarterly net profit?
The current quarterly net income of ALBO is -$37.80 M
What is the all time high quarterly net income for Albireo Pharma?
Albireo Pharma all-time high quarterly net profit is $57.09 M
What is Albireo Pharma quarterly net income year-on-year change?
Over the past year, ALBO quarterly net profit has changed by -$94.89 M (-166.22%)
What is Albireo Pharma TTM net profit?
The current TTM net income of ALBO is -$131.15 M
What is the all time high TTM net income for Albireo Pharma?
Albireo Pharma all-time high TTM net profit is -$846.00 K
What is Albireo Pharma TTM net income year-on-year change?
Over the past year, ALBO TTM net profit has changed by -$83.28 M (-173.98%)